FDA — authorised 17 December 2021
- Application: BLA761216
- Marketing authorisation holder: COHERUS BIOSCIENCES INC
- Local brand name: YUSIMRY
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 YUSIMRY in United States
FDA authorised YUSIMRY on 17 December 2021
Marketing authorisation
YUSIMRY in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is YUSIMRY approved in United States?
Yes. FDA authorised it on 17 December 2021.
Who is the marketing authorisation holder for YUSIMRY in United States?
COHERUS BIOSCIENCES INC holds the US marketing authorisation.